Growth Hormone Secretion and Leptin in Morbid Obesity before and after Biliopancreatic Diversion: Relationships with Insulin and Body Composition

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 1, 2004, Pages 174-180

  De Marinis, L ^a,c   Bianchi, A ^a   Mancini, A ^a   Gentilella, R ^a   Perrelli, M ^a   Giampietro, A ^a   Porcelli, T ^a   Tilaro, L ^a   Fusco, A ^a   Valle, D ^b   Tacchino, R M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ELI LILLY AND COMPANY   (United States)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; BILIOPANCREATIC BYPASS; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GROWTH HORMONE RELEASE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MEASUREMENT; MORBID OBESITY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM;

ADIPOSE TISSUE; ADULT; BILIOPANCREATIC DIVERSION; BODY COMPOSITION; BODY MASS INDEX; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HOMEOSTASIS; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MIDDLE AGED; OBESITY, MORBID; REGRESSION ANALYSIS;

EID: 10744229474     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021308     Document Type: Article

References (68)

1. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59
2. Scacchi M, Pincelli AI, Cavagnini F 1999 Growth hormone in obesity. Int J Obes Relat Metab Disord 23:260-271
3. Postel-Vinay MC, Saab C, Gourmelen M 1995 Nutritional status and growth hormone-binding protein. Horm Res 44:177-181
4. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim MB, Amit T 1992 The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 41:106-112
5. Kratzsch J, Schreiber G, Selisko T, Keller E, Pflaum CD, Strasburger CJ 1997 Measurement of serum exon 3-retaining growth hormone-binding protein in children and adolescents by radioimmunoassay. Horm Res 48:252-257
6. Minuto F, Barreca A, Del Monte P, Fortini P, Resentini M, Morabito F, Giordano G 1988 Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty. J Endocrinol Invest 11:489-495
7. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H 1995 Free insulin-like growth factors in human obesity. Metabolism 44(Suppl 4):37-44
8. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB 1997 Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 21:355-359
9. Argente J, Caballo N, Barrios V, Pozo J, Munoz MT, Chowen JA, Hernandez M 1997 Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short-and long-term weight reduction. J Clin Endocrinol Metab 82:2076-2083
10. Kolaczynski JW, Considine RV, Ohannesian JP, Marco C, Opentanova I, Nyce MR, Myint M, Caro JF1996 Responses of leptin to short-term festing and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 45:1511-1515
11. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannensian JP, Marco C, McKee LJ, Bauer TL, Caro JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
12. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161
13. Scholz GH, Englaro P, Thiele I, Scholz M, Klusmann T, Kellner K, Rascher W, Blum WF 1996 Dissociation of serum leptin concentration and body fat content during long term dietary intervention in obese individuals. Horm Metab Res 28:718-723
14. Sihna MK, Opentanova I, Ohanessian JP, Kolaczyski JW, Heiman ML, Hale J, Becker GW, Bowsher RR, Stephens TW, Caro JF 1996 Evidence of free and bound leptin in human circulation. J Clin Invest 98:1277-1282
15. De Marinis L, Mancini A, Valle D, Bianchi A, Miliardi D, Proto A, Lanzone A, Tacchino RM 1999 Plasma leptin levels after Biliopancreatic Diversion: dissociation with body mass index. J Clin Endocrinol Metab 84:2386-2389
16. Chu NF, Spiegelman D, Yu J, Rifai N, Hotamisligil GS, Rimm EB 2001 Plasma leptin concentrations and four-year weight gain among US men. Int J Obes Relat Metab Disord 25:346-353
17. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ 2002 Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol 283:E187-E192
18. Caro JF, KoIaczynski JW, Nyce MR, Ohannensian JP, Opentanova I, Goldman WH, Lynn RB, Zang P-L, Sihna MK, Considine RV 1996 Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161
19. Golden PL, Maccagnan TJ, Pardridge WM 1997 Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels J Clin Invest 99:14-18
20. Clement K, Garner C, Hager J, Philippi A, LeDuc C, Carey A, Harris TJR, Juri C, Cardon LR, Basdevant A, Demenais F, Guy-Grand B, North M, Froguel P 1996 Indication for linkage of the human ob gene region with extreme obesity. Diabetes 45:687-690
21. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD 1998 A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215
22. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG 1997 Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123
23. Ur E, Grossman A, Despres JP 1996 Obesity results as a consequence of glucocorticoid induced leptin resistance. Horm Metab Res 28:744-747
24. Ozata M, Dieguez C, Casanueva FF 2003 The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients. J Clin Endocrinol Metab 88:312-316
25. Castagneto M, De Gaetano A, Mingrone G, Tacchino R, Nanni G, Capristo E, Benedetti G, Tataranni PA, Greco AV1994 Normalization of insulin sensitivity in the obese patient after stable weight reduction with biliopancreatic diversion. Obes Surg 4:161-168
26. Sarson DL, Scopinaro N, Bloom SR 1981 Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 5:471-480
27. Chen D, Nylander AG, Rehfeld JF, Sundler F, Hakanson R 1993 Hypercholecystokininemia produced by pancreaticobiliary diversion causes gastrin-like effects on enterochromaffin-like cells in the stomach of rats subjected to portacaval shunting or antrectomy. Scand J Gasrroenterol 28:988-992
28. Perrelli M, Mancini A, Tacchino R, Bianchi A, Giampietro A, Miliardi D, De Marinis L, Body composition and energy expenditure in obese subjects before and after biliopancreatic diversion (BPD). Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, p 111 (Abstract OR34-4)
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28:412-419
30. Radziuk J 2000 Insulin sensitivity and its measurement: structural commonalities among the methods J Clin Endocrinol Metab 85:4426-4433
31. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M 2000 Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63
32. Daughaday WH, Mariz IK, Blethen SL 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 51:781-788
33. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298
34. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 41:85-89
35. Milliken LA, Going SB, Lohman TG 1996 Effects of variations in regional composition on soft tissue measurements by dual-energy x-ray absorptiometry. Int J Obes Relat Metab Disord 20:677-682
36. Tataranni PA, Ravussin E 1995 Use of x-ray absorptiometry in obese individuals. Am J Clin Nutr 62:730-734
37. Bertin E, Marcus C, Ruiz JC, Eschard JP, Leutenegger M 2000 Measurement of visceral adipose tissue by DXA combined with anthropometry in obese humans. Int J Obes Relat Metab Disord 24:263-270
38. Mazess RB, Barden HS, Bisek JP, Hanson J 1990 Dual-energy x-ray absorptiometry for total body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106-1112
39. Lee JH, Reed DR, Price RA 2001 Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord 25:1471-1473
40. Maccario M, Grottoli S, Procopio M, Oleandri SE, Rossetto R, Gauna C, Arvat E, Ghigo E 2000 The GH/IGF-I axis in obesity: influence of neuroendocrine and metabolic factors. Int J Obes Relat Metab Disord 24(Suppl 2):S96-S99
41. De Marinis L, Mancini A, Valle D, Tacchino RM, Bianchi A, Gentilella R, Perrelli M, Castagneto M, Gasbarrini G 1998 Evaluation of pre-and post-prandial growth hormone (GH)-releasing hormone-induced GH response in subjects with persistent body weight normalisation after biliopancreatic diversion. Int J Obes Relat Metab Disord 22:1011-1018
42. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA 1984 Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 311:1403-1407
43. Maccario M, Tassone F, Grottoli S, Rossetto R, Gauna C, Ghigo E 2002 Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann Endocrinol (Paris) 63:140-144
44. Mingrone G, De Gaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gasbarrini G 1997 Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 40:599-605
45. Melmed S 1984 Insulin suppresses growth hormone secretion by rat pituitary cells. J Clin Invest 73:1425-1433
46. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J, Skakkebae NE 1995 Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 80:1407-1415
47. Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva FF, Dieguez C1998 Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. J Clin Endocrinol Metab 83:4350-4354
48. Ciampelli M, Muzj G, Leoni F, Romualdi D, Belosi C, Cento RM, Lanzone A 2001 Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome. J Clin Endocrinol Metab 86:5324-5329
49. Van Dam PS, Smid HE, de Vries WR, Niesink M, Bolscher E, Waasdorp EJ, Dieguez C, Casanueva FF, Koppeschaar HP 2000 Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men. J Clin Endocrinol Metab 85:4706-4711
50. Mingrone G, Rosa G, Di Rocco P, Manco M, Capristo E, Castagneto M, Vettor R, Gasbarrini G, Greco AV 2002 Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-α reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord 26:1165-1172
51. Vettor R, Mingrone G, Manco M, Granzotto M, Milan G, Scarda A, Lombardi A, Greco AV, Federspil G 2003 Reduced expression of uncoupling proteins-2 and -3 in adipose tissue in post-obese patients submitted to biliopancreatic diversion. Eur J Endocrinol 148:543-550
52. Rosa G, Di Rocco P, Manco M, Greco AV, Castagneto M, Vidal H, Mingrone G 2003 Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients. Obes Res 11:176-182
53. Nam SY, Kim KR, Song YD, Lim SK, Lee HC, Huh KB 1999 GH-binding protein in obese men with varying glucose tolerance: relationship to body fat distribution, insulin secretion and the GH-IGF-I axis. Eur J Endocrinol 140:159-163
54. Isozaki O, Tsushima T, Miyakawa M, Demura H, Seki H 1999 Interaction between leptin and growth hormone (GH)/IGF-I axis. Endocr J 46(Suppl): S17-S24
55. Spurlock ME, Ranalletta MA, Cornelius SG, Frank GR, Willis GM, Ji S, Grant AL, Bidwell CA 1998 Leptin expression in porcine adipose tissue is not increased by endotoxin but is reduced by growth hormone. J Interferon Cytokine Res 18:1051-1058
56. Houseknecht KL, Portocarrero CP, Ji S, Lemenager R, Spurlock ME 2000 Growth hormone regulates leptin gene expression in bovine adipose tissue: correlation with adipose IGF-I expression. J Endocrinol 164:51-57
57. Florkowski CM, Collier GR, Zimmet PZ, Livesey JH, Espiner EA, Donald RA 1996 Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 45:769-773
58. De Marinis L, Mancini A, Gentilella R, Giampietro A, Bianchi A, Milardi D, Vezzosi C, Liberale I, Valle D, Effects of growth hormone replacement therapy on leptin levels in adult hypopituitaric subjects. Program of the 82nd Annual Meeting of The Endocrine Society, Toronto, Canada, 2000, p 537 (Abstract 2219)
59. Marzullo P, Buckway C, Pratt KL, Colao A, Guevara-Aguirre J, Rosenfeld RG 2002 Leptin concentrations in GH deficiency: the effect of GH insensitivity. J Clin Endocrinol Metab 87:540-545
60. Fors H, Matsuoka H, Bosaeus I, Rosberg S, Albertsson Wikland K, Bjarnason R 1999 Serum leptin levels correlate with growth hormone secretion and body fat in children. J Clin Endocrinol Metab 84:3586-3590
61. Fruehwald-Schultes B, Oltmanns KM, Toschek B, Sopke S, Kern W, Born J, Fehm HL, Peters 2002 A Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men. Metabolism 51:531-536
62. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, Stern JS, Havel PJ 1998 Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139:551-558
63. Wellhoener P, Fruehwald-Schultes B, Kern W, Dantz D, Kerner W, Born J, Fehm HL, Peters A 2000 Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 85:1267-1271
64. Boden G, Chen X, Kolaczynski JW, Polansky M 1997 Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100:1107-1113
65. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V 1998 Physiological insulinemia acutely modulates plasma leptin. Diabetes 47:544-549
66. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709
67. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M 2001 Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145:669-673
68. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ 200 Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623-1630